Basic Information
Basic information for MIR9-3HG-219-37aa
Peptide Name MIR9-3HG-219-37aa
Genome Position chr15:89397431-89397541[+]
Species Human
Peptide Sequence MAWKVSLRGNAAHHPPWGQGQATPALGRGLQQPESSQ
Peptide Length 37
Unique No (MIR9-3HG-201-37aa,MIR9-3HG-212-37aa,MIR9-3HG-213-37aa,MIR9-3HG-214-37aa,MIR9-3HG-218-37aa,MIR9-3HG-220-37aa,MIR9-3HG-221-37aa,MIR9-3HG-222-37aa,MIR9-3HG-226-37aa,MIR9-3HG-227-37aa,MIR9-3HG-233-37aa,MIR9-3HG-241-37aa,MIR9-3HG-246-37aa,MIR9-3HG-247-37aa,MIR9-3HG-251-37aa,MIR9-3HG-252-37aa,MIR9-3HG-253-37aa)
Grand Average of Hydropathicity -0.827
Relative Molecular Mass 4598.97
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000658194;MIR9-3HG-219
Transcript Length 4266
Coding Ability 0.4834
DNA Sequence Corresponding to Peptide ATGGCCTGGAAGGTGTCTCTGAGAGGTAATGCCGCACACCACCCTCCCTGGGGGCAGGGTCAGGCTACACCTGCCTTAGGTCGGGGGCTGCAGCAGCCTGAGAGCTCTCAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :